Get the app!
Back to Trades

Patel Samir Rashmikant

Director10% OwnerCIK 0001702447

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025–2026

Across 2 filings between 2025–2026, Patel Samir Rashmikant, Director, 10% Owner, has disclosed $349.7K in transactions — all concentrated in Akari Therapeutics Plc (AKTX). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Jul 17AKTX
Akari Therapeutics Plc
Patel Samir RashmikantDirector, 10% OwnerExercise$19.4K
Dec 18AKTX
Akari Therapeutics Plc
Patel Samir RashmikantDirector, 10% OwnerOther$330.3K

2 filings